Biotargetsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 72 days early.
- 202503/07/2026
- 202408/07/2025
- 202325/06/2024
- 202231/03/2023
- 202105/07/2022
- 202012/01/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board has the right to represent the company independently. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Przemysław Kopytoage 54 | 77 | $2,079.96 | 14% |
Mateusz Saganage 48 | 55 | $1,485.68 | 10% |
Magdalena Maria Staniszewskaage 52 | 418 | $11,291.19 | 76% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-04-01.
16 1090 2590 0000 0001 4738 1315- 88 1090 2590 0000 0001 4738 1183
- 60 1090 2590 0000 0001 4738 1299
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 15, 2021 | Aid for research and development projects: industrial research | $627.3K$627,259 | Marszałek Województwa Lubelskiego | |
| Jan 15, 2021 | Aid for research and development projects: experimental development | $33,155$33,155 | Marszałek Województwa Lubelskiego | |
| Jan 15, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $0$0 | Marszałek Województwa Lubelskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-04-01 | Development of a medicinal product in the form of an FSMP to support the immune system in the treatment of cancer and infectious diseases such as COVID-19 | $694.9K$694,936 | Regional Operational Programme of the Lubelskie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bulletprovesp. z o.o. | $867,545.53 | bulletprove.com | ||
| Medrisesp. z o.o. | $571,656.57 | medrise.pl | ||
| Nexbiosp. z o.o. | $186,582.40 | nexbio.pl | ||
| Innoeco Polskasp. z o.o. | $10,013.38 | innoeco.pl | ||
| Genovaris Medicalsp. z o.o. | $25.11 | genovaris.com | ||
| Oasis City Labsp. z o.o. | – | oasiscitylab.eu | ||
| Trivo.LifeP.S.A. | – | trivo.life | ||
| Harv-Esp. z o.o. | – | harv-e.eu | ||
| Kartolansp. z o.o. | – | kartolan.pl | ||
| Lubelski Instytut Badawczo-RozwojowyP.S.A. | – | libr-polska.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-17 | Share capital increase (5,000.00 PLN → 55,000.00 PLN) | |
| 2025-11-17 | PKD change (Removed: 72.11.Z, 72.19.Z; Added: 46.45.Z, 46.64.Z, 47.73.Z, 72.10.Z) | |
| 2021-04-07 | Address change (Ul. Głęboka 39, 20-621, Lublin → Ul. Głęboka 39, 20-612, Lublin) | |
| 2021-03-22 | Address change (Ul. Józefa Franczaka "lalka" 43, 20-325, Lublin → Ul. Głęboka 39, 20-621, Lublin) | |
| 2020-05-25 | Address change (Ul. Droga Męczenników Majdanka 181, 20-325, Lublin → Ul. Józefa Franczaka "lalka" 43, 20-325, Lublin) |
FAQ
Last updated: 2026-07-06